APPLICATION
ANDA091449
TYPE
ANDA
ORIGINAL APPROVAL
2011-03-22
LATEST ACTION
2023-04-26
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
LATANOPROSTPrescription
LATANOPROST 0.005% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2023-04-26Labeling · Supplement 10 · standardAP
2021-08-23Labeling · Supplement 7 · standardAP
2020-02-19Labeling · Supplement 6 · standardAP
2011-03-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.